Nath Bio-Genes (India) Limited Total Liabilities

Latest as of March 2026: Rs4.17 Billion INR ≈ $45.09 Million USD

Nath Bio-Genes (India) Limited total liabilities. Based on the latest financial reports, Nath Bio-Genes (India) Limited (NATHBIOGEN) has total liabilities worth Rs4.17 Billion INR (≈ $45.09 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Nath Bio-Genes (India) Limited (NATHBIOGEN) asset resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Nath Bio-Genes (India) Limited (2012–2026)

Total liabilities of Nath Bio-Genes (India) Limited from 2012 to 2026. This chart illustrates how Nath Bio-Genes (India) Limited's total liabilities have evolved over time, based on quarterly financial data. Explore Nath Bio-Genes (India) Limited long-term investment allocation to see how much of total assets are deployed in long-term investments.

Nath Bio-Genes (India) Limited Competitors by Total Liabilities

The table below lists competitors of Nath Bio-Genes (India) Limited ranked by their total liabilities.

Company	Country	Total Liabilities
Sh E & Chemical Co. Ltd. KO:002360	Korea	₩32.21 Billion
Imas Makina Sanayi AS IS:IMASM	Turkey	TL1.62 Billion
TOP Ships Inc. NASDAQ:TOPS	USA	$278.35 Million
Briacell Therapeutics Corp NASDAQ:BCTX	USA	$3.66 Million
Audacia SAS PA:ALAUD	France	€11.07 Million
Hanwha Chemical Corp Pref KO:009835	Korea	₩22.90 Trillion
Tigers Realm Coal Ltd AU:TIG	Australia	AU$46.17 Million
Champion Pacific Indonesia Tbk JK:IGAR	Indonesia	Rp133.55 Billion

Liability Composition Analysis (2012–2026)

This chart breaks down Nath Bio-Genes (India) Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Nath Bio-Genes (India) Limited balance sheet assets.

Liquidity & Leverage Metrics

Nath Bio-Genes (India) Limited Total Liabilities Ratios Explained

Nath Bio-Genes (India) Limited total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.97	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.61	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.38	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Nath Bio-Genes (India) Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Nath Bio-Genes (India) Limited (2012–2026)

The table below shows the annual total liabilities of Nath Bio-Genes (India) Limited from 2012 to 2026.

Year	Total Liabilities	Change
2026-03-31	Rs4.17 Billion ≈ $45.09 Million	+9.20%
2025-03-31	Rs3.82 Billion ≈ $41.29 Million	+41.25%
2024-03-31	Rs2.70 Billion ≈ $29.23 Million	+23.08%
2023-03-31	Rs2.20 Billion ≈ $23.75 Million	+9.85%
2022-03-31	Rs2.00 Billion ≈ $21.62 Million	+13.45%
2021-03-31	Rs1.76 Billion ≈ $19.06 Million	+2.26%
2020-03-31	Rs1.72 Billion ≈ $18.64 Million	+24.44%
2019-03-31	Rs1.38 Billion ≈ $14.98 Million	+35.80%
2018-03-31	Rs1.02 Billion ≈ $11.03 Million	-32.81%
2017-03-31	Rs1.52 Billion ≈ $16.41 Million	+4.38%
2016-03-31	Rs1.45 Billion ≈ $15.72 Million	+22.17%
2015-03-31	Rs1.19 Billion ≈ $12.87 Million	+10.04%
2014-03-31	Rs1.08 Billion ≈ $11.70 Million	+7.28%
2013-03-31	Rs1.01 Billion ≈ $10.90 Million	+35.81%
2012-03-31	Rs742.27 Million ≈ $8.03 Million	--

About Nath Bio-Genes (India) Limited

NSE:NATHBIOGEN India Agricultural Inputs

Market Cap

$27.75 Million

Rs2.57 Billion INR

Market Cap Rank

#23865 Global

#1315 in India

Share Price

Rs135.03

Change (1 day)

+1.78%

52-Week Range

Rs129.02 - Rs196.01

All Time High

Rs537.81